VP, Global Medical Affairs
bioMerieux/BioFire Diagnostics
Disclosure: bioMerieux (Employee)bioMerieux (Employee, Shareholder)
Christine C. Ginocchio, PhD MT(ASCP) is VP, Medical Affairs, bioMérieux, VP, Scientific and Medical Affairs, BioFire Diagnostics, and Professor of Medicine (retired), Zucker School of Medicine at Hofstra Northwell, NY. Previously, she was Senior Medical Director, Division of Infectious Disease Diagnostics, Department of Pathology and Laboratory Medicine, North Shore-LIJ Health System and Research Professor, Feinstein Institute for Medical Research, NY. She has 40 years’ experience in all phases of laboratory management and clinical diagnostics, including management of a large multi-hospital reference laboratory that performed diagnostic testing for regional hospitals, physician practices, clinics, extended care facilities and pharmaceutical clinical trials. She has been the principal investigator for more than 60 diagnostic industry and pharmaceutical clinical trials, including 23 studies of IVDs for US FDA clearance. Her areas of extra-mural funded research included HIV, CMV, respiratory viruses, HPV, antibiotic resistance and molecular diagnostics for infectious diseases. Her awards include the President’s Award and Irving Abrahams Award for outstanding basic science research, PASCV 2012 award in Diagnostic Virology and ASM 2013 BD Award for Research in Clinical Microbiology. Dr. Ginocchio’s Laboratory was instrumental in providing the first comprehensive published evaluation of molecular diagnostics for the 2009 Influenza H1N1 pandemic outbreak in New York. Dr. Ginocchio has more than 200 peer reviewed publications and poster presentations and has been an invited speaker at more than 200 National and International Scientific Conferences. She was the Co-Editor-in-Chief for the Journal of Clinical Virology (2006-2018), Section Editor, 10th, 11th, 12th editions of Manual of Clinical Microbiology, and on the Editorial Board for Clinical Microbiology Reviews. Dr. Ginocchio is currently a member of the Presidential Advisory Council on Combating Antimicrobial Resistant Bacteria (PACCARB), USA and the IDSA Diagnostics Committee.
